THE EFFECT OF HISTONE DEACETYLASE INHIBITOR ENTINOSTAT ON INVASION AND MIGRATION OF LUNG CANCER

被引：0
|
作者：
Zeng, Yunlong [1 ]
Xiong, Qingqing [2 ]
Wang, Tao [3 ]
机构：
[1] Jiangxi Chest Hosp, Dept Pharm, Nanchang 330006, Jiangxi, Peoples R China
[2] Jiangxi Chest Hosp, Dept Neurol, Nanchang 330006, Jiangxi, Peoples R China
[3] Jiangxi Chest Hosp, Dept Surg, Nanchang 330006, Jiangxi, Peoples R China
来源：
JOURNAL OF INVESTIGATIVE MEDICINE | 2023年 / 71卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
53
引用
收藏
页码：26 / 28
页数：3
相关论文
共 50 条
  • [1] The Histone Deacetylase Inhibitor Entinostat/Syndax 275 in Osteosarcoma
    Kiany, Simin
    Harrison, Douglas
    Gordon, Nancy
    CURRENT ADVANCES IN OSTEOSARCOMA: CLINICAL PERSPECTIVES: PAST, PRESENT AND FUTURE, 2ND EDITION, 2020, 1257 : 75 - 83
  • [2] Class I histone deacetylase inhibitor Entinostat sensitises prostate cancer cells to radiation
    McCullough, B.
    Manley, J.
    McDade, S.
    Wilson, M. LaBonte
    RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S330 - S331
  • [3] The histone deacetylase inhibitor Entinostat enhances polymer-mediated transgene expression in cancer cell lines
    Elmer, Jacob J.
    Christensen, Matthew D.
    Barua, Sutapa
    Lehrman, Jennifer
    Haynes, Karmella A.
    Rege, Kaushal
    BIOTECHNOLOGY AND BIOENGINEERING, 2016, 113 (06) : 1345 - 1356
  • [4] Histone deacetylase 5 promotes the proliferation and invasion of lung cancer cells
    Zhong, Lou
    Sun, Siyuan
    Yao, Sumei
    Han, Xiao
    Gu, Mingming
    Shi, Jiahai
    ONCOLOGY REPORTS, 2018, 40 (04) : 2224 - 2232
  • [5] Effect of histone deacetylase inhibitor on PD-L1 expression in lung cancer cells
    Natarajan, Umamaheswari
    Venkatesan, Thiagarajan
    Vijayaraghavan, R.
    Samuel, Shila
    Rathinavelu, Appu
    CANCER RESEARCH, 2019, 79 (13)
  • [6] Pharmacokinetic and pharmacodynamic analysis of patients treated with the histone deacetylase inhibitor entinostat in combination with erlotinib
    Lee, Min-Jung
    Adjei, Alex
    Bonomi, Philip
    Raez, Luis
    Drabkin, Harry
    Bodkin, David
    Trebel, Jane
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12)
  • [7] Identification of Jun loss promotes resistance to histone deacetylase inhibitor entinostat through Myc signaling in luminal breast cancer
    Maki Tanioka
    Kevin R. Mott
    Daniel P. Hollern
    Cheng Fan
    David B. Darr
    Charles M. Perou
    Genome Medicine, 10
  • [8] Histone Deacetylase Inhibitor Entinostat Inhibits Tumor-Initiating Cells in Triple-Negative Breast Cancer Cells
    Schech, Amanda
    Kazi, Armina
    Yu, Stephen
    Shah, Preeti
    Sabnis, Gauri
    MOLECULAR CANCER THERAPEUTICS, 2015, 14 (08) : 1848 - 1857
  • [9] Identification of Jun loss promotes resistance to histone deacetylase inhibitor entinostat through Myc signaling in luminal breast cancer
    Tanioka, Maki
    Mott, Kevin R.
    Hollern, Daniel P.
    Fan, Cheng
    Darr, David B.
    Perou, Charles M.
    GENOME MEDICINE, 2018, 10
  • [10] Entinostat finds a path: A new study elucidates effects of the histone deacetylase inhibitor on the immune system
    Surolia, Ira
    Bates, Susan E.
    CANCER, 2018, 124 (24) : 4597 - 4600
12345